pyridoxine has been researched along with Cerebral Pseudosclerosis in 21 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Beside, once the diagnosis is made, Wilson's disease can be effectively treated." | 2.38 | [Wilson's disease]. ( Cramarossa, L; D'Angelo, D; D'Ascanio, I; Ferri, GB; Piane, E, 1992) |
| "Refractory rickets with Wilson's disease has been infrequently reported in literature." | 1.37 | Neurological Wilson's disease with refractory rickets. ( Aneja, S; Kaur, S; Krishnamurthy, S; Maheshwari, A; Patra, S; Seth, A, 2011) |
| "Wilson disease is an autosomal recessive disorder of copper metabolism in which copper is deposited in the brain and liver." | 1.34 | Wilson disease with visceral leishmaniasis: an extremely uncommon presentation. ( Bhattacharya, SK; Bimal, S; Das, P; Das, VN; Kumar, N; Lal, CS; Pandey, K; Singh, D; Sinha, PK; Topno, RK; Verma, N; Verma, RB, 2007) |
| "Wilson's Disease is an inherited disorder of copper metabolism." | 1.29 | [Wilson's disease: a review apropos of a clinical experience in 16 patients]. ( Alarcón, T; Brinck, P; González, M; Miranda, M; Roessler, JL; Troncoso Sch, M; Villagra, R, 1995) |
| "A patient with Wilson's disease underwent neuropsychological and electrophysiological examination 4 months following symptom onset." | 1.27 | Neuropsychological and electrophysiological examination of a patient with Wilson's disease. ( Bornstein, RA; Ho, K; McLean, DR, 1985) |
| "Untreated Wilson's disease usually causes infertility or abortion, as a result of increased intrauterine copper level." | 1.27 | [Teratogenic risk during treatment of Wilson disease]. ( Mathieu, M; Piussan, C, 1985) |
| "All patients with Wilson disease had hepatic copper levels greater than 400 microgram/gm dry weight, whereas patients with chronic active hepatitis had levels less than 300 microgram/gm dry weight." | 1.26 | Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children. ( Grand, RJ; Perman, JA; Watkins, JB; Werlin, SL, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (66.67) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotalová, R | 1 |
| Jirsa, M | 1 |
| Vávrová, V | 1 |
| Vrábelová-Pouchlá, S | 1 |
| Macek, M | 1 |
| Kaur, S | 1 |
| Maheshwari, A | 1 |
| Aneja, S | 1 |
| Patra, S | 1 |
| Krishnamurthy, S | 1 |
| Seth, A | 1 |
| Noureen, N | 1 |
| Rana, MT | 1 |
| TU, JB | 2 |
| BLACKWELL, RQ | 2 |
| COOPER, WC | 2 |
| CHEN, YH | 1 |
| HOU, TY | 1 |
| Pandey, K | 1 |
| Sinha, PK | 1 |
| Das, VN | 1 |
| Kumar, N | 1 |
| Verma, N | 1 |
| Bimal, S | 1 |
| Lal, CS | 1 |
| Topno, RK | 1 |
| Singh, D | 1 |
| Verma, RB | 1 |
| Bhattacharya, SK | 1 |
| Das, P | 1 |
| Lekar', PG | 1 |
| Makarova, VA | 1 |
| Botvinnik, VS | 1 |
| Miranda, M | 1 |
| Brinck, P | 1 |
| Roessler, JL | 1 |
| Troncoso Sch, M | 1 |
| González, M | 1 |
| Alarcón, T | 1 |
| Villagra, R | 1 |
| Jayasundar, R | 1 |
| Sahani, AK | 1 |
| Gaikwad, S | 1 |
| Singh, S | 1 |
| Behari, M | 1 |
| Walshe, JM | 1 |
| Perman, JA | 1 |
| Werlin, SL | 1 |
| Grand, RJ | 1 |
| Watkins, JB | 1 |
| Cramarossa, L | 1 |
| D'Angelo, D | 1 |
| D'Ascanio, I | 1 |
| Ferri, GB | 1 |
| Piane, E | 1 |
| Longhi, R | 1 |
| Riva, E | 1 |
| Rottoli, A | 1 |
| Valsasina, R | 1 |
| Pinelli, P | 1 |
| Giovannini, M | 1 |
| Vakharlovskiĭ, VG | 1 |
| Verovaia, AV | 1 |
| Bornstein, RA | 1 |
| McLean, DR | 1 |
| Ho, K | 1 |
| Piussan, C | 1 |
| Mathieu, M | 1 |
| Mera, A | 1 |
| Werner, T | 1 |
| Weinmann, HM | 1 |
| Damaske, E | 1 |
| Althoff, W | 1 |
| Tkachev, RA | 1 |
| Markova, ED | 1 |
| Gotovtseva, EV | 1 |
| Barkhatova, VP | 1 |
| Ivanova-Smolenskaia, IA | 1 |
| Brailski, C | 1 |
| Kolarski, V | 1 |
| Krastev, I | 1 |
3 reviews available for pyridoxine and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Brief observations on the management of Wilson's disease.
Topics: Chelating Agents; Hepatolenticular Degeneration; Humans; Penicillamine; Pyridoxine | 1977 |
[Wilson's disease].
Topics: Acetates; Acetic Acid; Adult; Diagnosis, Differential; Diet; Female; Hepatolenticular Degeneration; | 1992 |
[10 years of penicillamine].
Topics: Cystinuria; Drug Eruptions; Gold; Hepatolenticular Degeneration; Humans; Lead Poisoning; Leukopenia; | 1966 |
18 other studies available for pyridoxine and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Wilson disease as a cause of liver injury in cystic fibrosis.
Topics: Chelating Agents; Child; Child, Preschool; Cystic Fibrosis; Diagnosis, Differential; Genetic Testing | 2009 |
Neurological Wilson's disease with refractory rickets.
Topics: Adolescent; Calcitriol; Consanguinity; Drug Therapy, Combination; Familial Hypophosphatemic Rickets; | 2011 |
Neurological Wilson disease in children: a three years experience from Multan.
Topics: Adolescent; Age Distribution; Age of Onset; Astringents; Chelating Agents; Child; Child, Preschool; | 2011 |
STUDIES OF PYRIDOXAL-PENICILLAMINE ANTAGONISM IN THE HUMAN.
Topics: Hepatolenticular Degeneration; Humans; Metabolism; Penicillamine; Pharmacology; Pyridoxal; Pyridoxin | 1964 |
TREATMENT OF HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE) IN THE ASYMPTOMATIC STAGE.
Topics: Asian People; Child; Copper; Diet; Diet Therapy; Drug Therapy; Electroencephalography; Feces; Hepato | 1965 |
Wilson disease with visceral leishmaniasis: an extremely uncommon presentation.
Topics: Adolescent; Chelating Agents; Hepatolenticular Degeneration; Humans; Leishmaniasis, Visceral; Male; | 2007 |
[Treatment of hepatocerebral dystrophy (Wilson-Westphal-Konovalov's disease)].
Topics: Amino Acids; Ceruloplasmin; Diet Therapy; Drug Evaluation; Drug Therapy, Combination; Hepatolenticul | 1981 |
[Wilson's disease: a review apropos of a clinical experience in 16 patients].
Topics: Adolescent; Adult; Central Nervous System Diseases; Ceruloplasmin; Child; Child, Preschool; Copper; | 1995 |
Proton MR spectroscopy of basal ganglia in Wilson's disease: case report and review of literature.
Topics: Adolescent; Basal Ganglia; Chelating Agents; Child; Choline; Creatine; Drug Therapy, Combination; Fa | 2002 |
Laboratory measures of copper metabolism in the differentiation of chronic active hepatitis and Wilson disease in children.
Topics: Adolescent; Adult; Azathioprine; Ceruloplasmin; Child; Child, Preschool; Chronic Disease; Copper; Di | 1979 |
Nuclear magnetic resonance brain study in a case of Wilson disease.
Topics: Adolescent; Brain; Hepatolenticular Degeneration; Humans; Magnetic Resonance Spectroscopy; Male; Pen | 1989 |
[Characteristics of visceral manifestations of Wilson-Konovalov disease].
Topics: Adult; Diagnosis, Differential; Female; Hepatitis; Hepatolenticular Degeneration; Humans; Jaundice; | 1989 |
Neuropsychological and electrophysiological examination of a patient with Wilson's disease.
Topics: Adult; Brain Stem; Copper; Drug Therapy, Combination; Electrodiagnosis; Electroencephalography; Evok | 1985 |
[Teratogenic risk during treatment of Wilson disease].
Topics: Adult; Congenital Abnormalities; Copper; Female; Fetus; Hepatolenticular Degeneration; Humans; Infan | 1985 |
Uncommon EEG findings in hepato-lenticular degeneration.
Topics: Cerebral Cortex; Child; Dimercaprol; Electroencephalography; Epilepsy; Female; Hepatolenticular Dege | 1969 |
[Optic neuritis in a child with Wilson's disease].
Topics: Adolescent; Copper; Hepatolenticular Degeneration; Humans; Long-Term Care; Male; Optic Atrophy; Opti | 1972 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphe | 1973 |
[Studies of the hepatolenticular degeneration and results of its continuous therapy].
Topics: Acid Phosphatase; Adolescent; Adult; Alkaline Phosphatase; Blood Proteins; Chronic Disease; Depressi | 1970 |